These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32117196)

  • 1. KSHV: Immune Modulation and Immunotherapy.
    Broussard G; Damania B
    Front Immunol; 2019; 10():3084. PubMed ID: 32117196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
    Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
    Alomari N; Totonchy J
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
    Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
    J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.
    Qin Z; Peruzzi F; Reiss K; Dai L
    Viruses; 2014 Nov; 6(11):4571-80. PubMed ID: 25421888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay between KSHV Infection and DNA-Sensing Pathways.
    Han C; Gui C; Dong S; Lan K
    Viruses; 2024 May; 16(5):. PubMed ID: 38793630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of viral mimics of cellular genes to KSHV infection and disease.
    Sakakibara S; Tosato G
    Viruses; 2014 Sep; 6(9):3472-86. PubMed ID: 25243371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of Kaposi's sarcoma-associated herpesvirus.
    Bryan BA; Dyson OF; McCubrey JA; Akula SM
    Front Biosci; 2005 Sep; 10():2882-91. PubMed ID: 15970542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases.
    Pringle ES; Wertman J; Melong N; Coombs AJ; Young AL; O'Leary D; Veinotte C; Robinson CA; Ha MN; Dellaire G; Druley TE; McCormick C; Berman JN
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31861850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.
    Giffin L; West JA; Damania B
    mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
    J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    Liu X; Happel C; Ziegelbauer JM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma.
    Ngalamika O; Munsaka S
    J Immunol Res; 2020; 2020():8852221. PubMed ID: 33294468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.
    He M; Cheng F; da Silva SR; Tan B; Sorel O; Gruffaz M; Li T; Gao SJ
    Cancer Treat Res; 2019; 177():23-62. PubMed ID: 30523620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.